203 related articles for article (PubMed ID: 24725598)
1. Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies.
Wan YD; Sun TW; Kan QC; Guan FX; Zhang SG
Crit Care; 2014 Apr; 18(2):R71. PubMed ID: 24725598
[TBL] [Abstract][Full Text] [Related]
2. Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies.
Horita N; Miyazawa N; Kojima R; Inoue M; Ishigatsubo Y; Ueda A; Kaneko T
Respir Res; 2014 Jul; 15(1):80. PubMed ID: 25029928
[TBL] [Abstract][Full Text] [Related]
3. Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies.
Lytras T; Nikolopoulos G; Bonovas S
World J Gastroenterol; 2014 Feb; 20(7):1858-70. PubMed ID: 24587664
[TBL] [Abstract][Full Text] [Related]
4. Understanding the potential role of statins in pneumonia and sepsis.
Yende S; Milbrandt EB; Kellum JA; Kong L; Delude RL; Weissfeld LA; Angus DC
Crit Care Med; 2011 Aug; 39(8):1871-8. PubMed ID: 21516038
[TBL] [Abstract][Full Text] [Related]
5. Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.
Macedo AF; Taylor FC; Casas JP; Adler A; Prieto-Merino D; Ebrahim S
BMC Med; 2014 Mar; 12():51. PubMed ID: 24655568
[TBL] [Abstract][Full Text] [Related]
6. Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.
Bonovas S; Filioussi K; Tsantes A; Sitaras NM
Br J Clin Pharmacol; 2007 Sep; 64(3):255-62. PubMed ID: 17578480
[TBL] [Abstract][Full Text] [Related]
7. Statin Use and Risk of Cirrhosis and Related Complications in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.
Kim RG; Loomba R; Prokop LJ; Singh S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1521-1530.e8. PubMed ID: 28479502
[TBL] [Abstract][Full Text] [Related]
8. Statin withdrawal and treating COVID-19 patients.
Fedson DS
Pharmacol Res Perspect; 2021 Dec; 9(6):e00861. PubMed ID: 34708573
[TBL] [Abstract][Full Text] [Related]
9. Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins.
Danaei G; Tavakkoli M; Hernán MA
Am J Epidemiol; 2012 Feb; 175(4):250-62. PubMed ID: 22223710
[TBL] [Abstract][Full Text] [Related]
10. Statin use and mortality of patients with prostate cancer: a meta-analysis.
Meng Y; Liao YB; Xu P; Wei WR; Wang J
Onco Targets Ther; 2016; 9():1689-96. PubMed ID: 27051303
[TBL] [Abstract][Full Text] [Related]
11. Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies.
Pradelli D; Soranna D; Zambon A; Catapano A; Mancia G; La Vecchia C; Corrao G
Cancer Med; 2015 May; 4(5):770-80. PubMed ID: 25809667
[TBL] [Abstract][Full Text] [Related]
12. Avoidable flaws in observational analyses: an application to statins and cancer.
Dickerman BA; García-Albéniz X; Logan RW; Denaxas S; Hernán MA
Nat Med; 2019 Oct; 25(10):1601-1606. PubMed ID: 31591592
[TBL] [Abstract][Full Text] [Related]
13. Can statins reduce risk of lung cancer, especially among elderly people? A meta-analysis.
Deng Z; Zhang S; Yi L; Chen S
Chin J Cancer Res; 2013 Dec; 25(6):679-88. PubMed ID: 24385695
[TBL] [Abstract][Full Text] [Related]
14. Role of obesity in lower mortality risk in sepsis: a meta-analysis of observational studies.
Lu Y; Ma J; Ma J; Ji D
Am J Transl Res; 2024; 16(5):1880-1890. PubMed ID: 38883384
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in a meta-analysis: randomized controlled trials versus observational studies.
Kotani Y; Yamamoto T; Shibata T; Hayashi Y
Intensive Care Med; 2024 Mar; 50(3):480-482. PubMed ID: 38329480
[No Abstract] [Full Text] [Related]
16. Heterogeneity in a meta-analysis: randomized controlled trials versus observational studies. Author's reply.
Schuurmans J; Veelo DP; Vlaar APJ; Schenk J
Intensive Care Med; 2024 Mar; 50(3):483-484. PubMed ID: 38421386
[No Abstract] [Full Text] [Related]
17. Statin use and survival among ESKD patients hospitalized with sepsis.
Yu AS; Liang B; Yang ST; Kim BJ; Huang CW; Sim JJ
Clin Kidney J; 2021 Jun; 14(6):1710-1712. PubMed ID: 34276978
[No Abstract] [Full Text] [Related]
18. Heterogeneity of Sepsis Presentations and Mortality Rates.
Biebelberg B; Rhee C; Chen T; McKenna C; Klompas M
Ann Intern Med; 2024 May; ():. PubMed ID: 38801775
[No Abstract] [Full Text] [Related]
19. Statin therapy and mortality from sepsis: a meta-analysis of randomized trials.
Deshpande A; Pasupuleti V; Rothberg MB
Am J Med; 2015 Apr; 128(4):410-7.e1. PubMed ID: 25526798
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin for sepsis-associated acute respiratory distress syndrome.
; Truwit JD; Bernard GR; Steingrub J; Matthay MA; Liu KD; Albertson TE; Brower RG; Shanholtz C; Rock P; Douglas IS; deBoisblanc BP; Hough CL; Hite RD; Thompson BT
N Engl J Med; 2014 Jun; 370(23):2191-200. PubMed ID: 24835849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
